LivaNova (NASDAQ:LIVN) Shares Gap Up to $48.79

LivaNova PLC (NASDAQ:LIVN) gapped up prior to trading on Tuesday . The stock had previously closed at $48.79, but opened at $50.37. LivaNova shares last traded at $51.38, with a volume of 59,088 shares traded.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on LIVN shares. Needham & Company LLC increased their price objective on LivaNova from $72.00 to $75.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Stifel Nicolaus increased their price target on shares of LivaNova from $70.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, July 25th. Robert W. Baird upgraded shares of LivaNova from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $55.00 to $66.00 in a report on Tuesday. Finally, Baird R W raised LivaNova from a “hold” rating to a “strong-buy” rating in a research report on Tuesday. One analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $70.80.

LivaNova Stock Up 0.1 %

The firm has a market capitalization of $2.77 billion, a price-to-earnings ratio of -85.12 and a beta of 1.00. The firm has a fifty day moving average price of $48.88 and a 200 day moving average price of $53.42. The company has a current ratio of 3.45, a quick ratio of 2.94 and a debt-to-equity ratio of 0.49.

LivaNova (NASDAQ:LIVN) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.66 by $0.15. LivaNova had a positive return on equity of 13.77% and a negative net margin of 1.37%. The company had revenue of $318.60 million for the quarter, compared to analyst estimates of $305.05 million. Sell-side analysts anticipate that LivaNova PLC will post 2.58 EPS for the current fiscal year.

Institutional Investors Weigh In On LivaNova

Institutional investors have recently made changes to their positions in the stock. Fifth Third Bancorp increased its stake in LivaNova by 97.1% in the second quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock valued at $37,000 after purchasing an additional 332 shares in the last quarter. Hexagon Capital Partners LLC grew its holdings in shares of LivaNova by 117.8% in the 2nd quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock valued at $37,000 after buying an additional 370 shares during the period. Lazard Asset Management LLC bought a new stake in shares of LivaNova in the 1st quarter valued at $84,000. Canada Pension Plan Investment Board acquired a new stake in LivaNova during the 2nd quarter worth $88,000. Finally, Acadian Asset Management LLC acquired a new stake in LivaNova during the 1st quarter worth $94,000. 97.64% of the stock is owned by institutional investors and hedge funds.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.